|
|
|
|
|
|
|
|
14 |
|
|
|
Organizing for Innovation: Motivating and Integrating R&D |
|
|
|
Teaching Note: Managing Innovation
Teaching Note: Incentives in research and development
|
|
|
2 pager #5 due |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15 |
|
|
|
Case: Siemens AG: Global Development Strategy (A) |
|
|
|
Case: Siemens AG: Global Development Strategy (A) (HBS # 9-602-061) |
|
|
What should Siemens do with respect to NetManager?
More broadly, what longer term recommendations would you make to Siemens as to how they should organizatize their development activities?
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16 |
|
|
|
Dealing with Discontinuities |
|
|
|
Henderson, R.M., and K. Clark. "Architectural Innovation: The Reconfiguration of Existing Product Technologies and the Failure of Established Firms." Administrative Science Quarterly 35 (1990): pp. 9-30.
"Managing Innovation in the Information Age." Harvard Business Review (January-February 1994): pp. 100-106.
|
|
|
How does Henderson and Clarks' explanation for the failure of established firms differ from Christiansen's?
Might there be other reasons that established companies have trouble negotiating discontinuities? List at least three.
What are the pros and cons of the various organizational mechanisms available to "deal with discontinuities"?
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17 |
|
|
|
Case: Synthes |
|
|
|
Synthes (HBS # 9-502-008) |
|
|
Should Synthes develop "bioresorbable internal fixation devices"? If so, why and how? If not, why not? |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
Case: R.R. Donnelley and Sons: The Digital Division |
|
|
|
R.R. Donnelley & Sons: The Digital Division (HBS # 9-396-154) |
|
|
Should Donnelley have entered the digital business in the first place? Why or why not?
Given that they entered, was it a good idea to set up a separate division?
What should Donnelley do now with respect to digital technology?
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19 |
|
|
|
Case: Intel Capital: The Berkeley Networks Investment |
|
|
|
Intel Capital: The Berkeley Networks Investment (HBS # 9-600-069) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20 |
|
|
|
Case: Corporate New Ventures at Procter and Gamble |
|
|
|
Corporate New Ventures at Procter & Gamble (9-897-088) |
|
|
Compare and contrast the structure and processes that P&G has created with those created by Intel in the Intel Capital case. Do you expect P&G New Ventures to be successful? Why or why not? What recommendations would you make to Craig Wynett going forward? |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21 |
|
|
|
Case: Alza/Ciba (1): Structuring a Deal? |
|
|
|
Half the study groups in the class will play the role of managers at Alza, half will play the role of Ciba. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22 |
|
|
|
Case: Alza/Ciba (2): Managing the Relationship, 1977-1979 |
|
|
|
Cases will be distributed in class 20 |
|
|
|
|
|
|
|
|
|
|